Vimarsana
Biggest News Aggregation in the World

Page 48 - Accessed August News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed August Today - Breaking & Trending Today

Sandoz announces generic Treprostinil Injection now also available for subcutaneous route of administration to treat PAH patients in US - Vimarsana News

Sandoz announces generic Treprostinil Injection now also available for subcutaneous route of administration to treat PAH patients in US

/PRNewswire/ -- Sandoz today announced Treprostinil Injection, a generic Remodulin®, is now also available for subcutaneous ("SC") administration to treat...

Investegate |Sanofi Announcements | Sanofi: Early amcenestrant data featured at ASCO support its potential to become a new endocrine backbone therapy for ER+/HER2- breast cancer - Vimarsana News

Investegate |Sanofi Announcements | Sanofi: Early amcenestrant data featured at ASCO support its potential to become a new endocrine backbone therapy for ER+/HER2- breast cancer

no ocular findings and an overall safety profile in line with what we saw in the monotherapy setting. It’s notable to see this kind of activity in patients with ER+ metastatic breast cancer, where there is a clear need for new therapeutic options.” In this preliminary analysis from the open-label AMEERA-1 study, amcenestrant was evaluated in dose escalation cohorts (Part C) at 200mg (n=9) and 400mg (n=6) daily and in a dose expansion cohort (Part D; n=30) at 200mg daily, all in combination with a standard dose of palbociclib. Eligible patients included post-menopausal women with ER+/HER...

Frontiers | No Association Between Statin Use and the Prognosis of Endometrial Cancer in Women With Type 2 Diabetes - Vimarsana News

Frontiers | No Association Between Statin Use and the Prognosis of Endometrial Cancer in Women With Type 2 Diabetes

4 1PEDEGO Research Unit, Medical Research Center Oulu, Department of Obstetrics and Gynecology, Oulu University Hospital and University of Oulu, Oulu, Finland 2Cancer and Translational Medicine Research Unit, Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland 3Department of Obstetrics and Gynecology, Central Finland Central Hospital, Jyväskylä, Finland 4Department of Oncology, University of Helsinki and Helsinki University Comprehensive Cancer Center, Helsinki, Finland Preclinical studies have suggested statins have antiproliferative and anti-metastatic ...

Global Blood Therapeutics, Inc.: GBT Announces Upcoming Data Presentations at European Hematology Association (EHA) 2021 Virtual Congress - Vimarsana News

Global Blood Therapeutics, Inc.: GBT Announces Upcoming Data Presentations at European Hematology Association (EHA) 2021 Virtual Congress

New Oxbryta, taking place online June 9-17, 2021. Results from an analysis of the Phase 2a HOPE-KIDS 1 Study (GBT440-007) in children with SCD ages 4 to 11 years treated with Oxbryta (voxelotor) tablets

GENFIT announces the launch by Labcorp of NASHnext® A Novel Noninvasive Diagnostic Test Powered ... - Vimarsana News

GENFIT announces the launch by Labcorp of NASHnext® A Novel Noninvasive Diagnostic Test Powered ...

More from AP

Source: apnews.com